Skip to main content
. 2019 Dec 18;35(4):917–928. doi: 10.3904/kjim.2019.218

Figure 1.

Figure 1.

The stepwise approach for patient selection. HIV, human immunodeficiency virus; AZA, azathioprine; CsA, cyclosporine A; MMF, mycophenolate mofetil; HCTZ, hydrochlorothiazide; NMSC, non-melanoma skin cancer. aHaving at least three prescriptions of HCTZ prior to the first diagnosis of skin cancer (NMSC, melanoma) or on June, 30, 2017.